The gut microbiome in systemic lupus erythematosus: lessons from rheumatic fever

被引:0
作者
Gregg J. Silverman
Doua F. Azzouz
Nicolas Gisch
Abhimanyu Amarnani
机构
[1] NYU Grossman School of Medicine,Department of Medicine
[2] Leibniz Lung Center,Division of Bioanalytical Chemistry, Priority Area Infections, Research Center Borstel
来源
Nature Reviews Rheumatology | 2024年 / 20卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
For more than a century, certain bacterial infections that can breach the skin and mucosal barriers have been implicated as common triggers of autoimmune syndromes, especially post-infection autoimmune diseases that include rheumatic fever and post-streptococcal glomerulonephritis. However, only in the past few years has the importance of imbalances within our own commensal microbiota communities, and within the gut, in the absence of infection, in promoting autoimmune pathogenesis become fully appreciated. A diversity of species and mechanisms have been implicated, including disruption of the gut barrier. Emerging data suggest that expansions (or blooms) of pathobiont species are involved in autoimmune pathogenesis and stimulate clonal expansion of T cells and B cells that recognize microbial antigens. This Review discusses the relationship between the gut microbiome and the immune system, and the potential consequence of disrupting the community balance in terms of autoimmune development, focusing on systemic lupus erythematosus. Notably, inter-relationships between expansions of certain members within gut microbiota communities and concurrent autoimmune responses bear features reminiscent of classical post-infection autoimmune disease. From such insights, new therapeutic opportunities are being considered to restore the balance within microbiota communities or re-establishing the gut-barrier integrity to reinforce immune homeostasis in the host.
引用
收藏
页码:143 / 157
页数:14
相关论文
共 277 条
[1]  
Barber MRW(2021)Global epidemiology of systemic lupus erythematosus Nat. Rev. Rheumatol. 17 515-532
[2]  
Dinse GE(2020)Increasing prevalence of antinuclear antibodies in the United States Arthritis Rheumatol. 72 1026-1035
[3]  
Aringer M(2019)2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus Arthritis Rheumatol. 71 1400-1412
[4]  
Miyauchi E(2023)The impact of the gut microbiome on extra-intestinal autoimmune diseases Nat. Rev. Immunol. 23 9-23
[5]  
Shimokawa C(2020)Lupus nephritis Nat. Rev. Dis. Prim. 6 7-464
[6]  
Steimle A(1992)Serologic studies of monozygotic twins with systemic lupus erythematosus Arthritis Rheum. 35 457-1526
[7]  
Desai MS(2015)Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families JAMA Intern. Med. 175 1518-544
[8]  
Ohno H(2018)Concordance of autoimmune disease in a nationwide Danish systemic lupus erythematosus twin cohort Semin. Arthritis Rheum. 47 538-1756
[9]  
Anders H-J(2020)Genome-wide assessment of genetic risk for systemic lupus erythematosus and disease severity Hum. Mol. Genet. 29 1745-i21
[10]  
Reichlin M(2017)Transancestral mapping and genetic load in systemic lupus erythematosus Nat. Commun. 8 i15-320